News
Medical marijuana >5% THC as a pharmaceutical raw material in pharmacy compounding – clinical applications
Learn about the clinical applications and pharmacy compounding model of medical marijuana with >5% THC in Poland.
From the very beginning, we focus on the highest quality. Our priority is that every batch of pharmaceutical raw material meets all quality and regulatory requirements.
We focus on patients every day. Each stage of product development is carried out with effective and safe medical solutions in mind.
Technology and research are our foundation. We invest in modern solutions and advanced production processes, constantly raising our standards.
We plan not only to produce the highest quality pharmaceutical raw materials, but also to provide services in the packaging of other raw materials, perform advanced laboratory analyses, and offer consulting services.
We are passionate about hemp. Our team pays attention to every single detail, wanting to challenge stereotypes and educate about the properties of medical marijuana.
Cultivation standard
We grow plants in the GACP standard, controlling temperature and air humidity, carbon dioxide (CO2), light intensity and the amount of µmol per plant. These rooms are adapted to grow up to 2000 plants in one room. Cultivation takes place under controlled hygienic conditions and in accordance with procedures.
Manufacturing standard
The manufacturing process takes place after transferring the dried product from the GACP zone to the GMP zone. The GMP process is carried out in cleanliness class D, appropriately adapted to the production of pharmaceutical raw materials, where process parameters are strictly controlled to maintain the highest possible quality of the final product.
Learn about the clinical applications and pharmacy compounding model of medical marijuana with >5% THC in Poland.